Avantor, Inc. Aktie News

NEW YORK--(BUSINESS WIRE)---- $AVTR #AVTR--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a lead...

Integrated sterile sampling and PUPSIT solutions streamline bioprocessing, enhance flexibility, and reduce risk while accelerating in-process decisions RADNOR, Pa. , Oct. 30, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the launch of its...

Avantor, Inc. ( AVTR ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Allison Hosak - Senior VP of Global Communications & Brand Emmanuel Ligner - President & CEO R. Jones - Executive VP & CFO Conference Call Participants Vijay Kumar - Evercore ISI Institutional Equities, Research Division Michael Ryskin - BofA Securities, Research Division Daniel Brennan - TD Cowen, Re...

Net sales of $1.62 billion, decrease of 5% Net loss of $712 million and diluted GAAP loss per share of $1.04, including a non-cash goodwill impairment charge of $785 million Adjusted EBITDA of $268 million; adjusted EPS of $0.22 Operating cash flow of $207 million; free cash flow of $172 million Company announces $500 million share repurchase authorization, reflecting confidence in cash generat...

New product line will enable secure chain-of-identity, enhanced traceability, and digital process control in pharmaceutical and clinical workflows – supporting the growing demand for individualized therapies RADNOR, Pa. and CHICAGO , Oct. 23, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and...

RADNOR, Pa. and PHILADELPHIA, Oct. 15, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced a strategic partnership with BlueWhale Bio, a commercial-stage company dedicated to transforming immune cell therapy manufacturing and addressing the unm...

Gregory L. Summe to Serve as Next Chairman of the Board Beginning on January 1, 2026 Jonathan Peacock to Step Down After Nearly Nine Years of Dedicated Service to the Board RADNOR, Pa. , Oct. 13, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announce...

Brings more than three decades of leadership experience in the life sciences industry RADNOR, Pa. , Oct. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Gregory T.